{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-074165","form_type":"8-K","ticker":"RLMD","cik":"0001553643","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2023-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.279550+00:00","generated_at":"2026-06-10T23:23:03.206511+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Board member Eric Schmidt resigns; cites compliance for new sell-side analyst role","bullets":["Eric Schmidt resigned from the Board effective September 5, 2023, with no disagreement with the company or management.","Resignation due to compliance requirements from his new role as a sell-side equity analyst at a Wall Street investment banking firm.","Schmidt served as a Class I director since 2019, chaired the Audit Committee, and was on the Governance Committee.","No replacement has been announced for the vacant board position."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-074165","json":"https://secwatch.observer/filing/0001213900-23-074165.json","markdown":"https://secwatch.observer/filing/0001213900-23-074165.md","text":"https://secwatch.observer/filing/0001213900-23-074165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/0001213900-23-074165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/ea184757-8k_relmada.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:23:03.206511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0fbb68134","claim":"Eric Schmidt resigned as Member of the Board of Directors at RELMADA THERAPEUTICS, INC..","evidence_excerpt":"On September 5, 2023, Eric Schmidt, a member of the Board of Directors (the “Board”) of Relmada Therapeutics, Inc. (the “Company”), notified the Company that he would resign from the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/0001213900-23-074165-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}